Home > Boards > US Listed > Biotechs > Biohaven Pharmceuticals (BHVN)

Low volume, hope this take off.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
investor86 Member Profile
 
Followed By 33
Posts 1,841
Boards Moderated 0
Alias Born 01/09/09
160x600 placeholder
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/18/2019 6:02:55 AM
Biohaven Announces Proposed Public Offering Of Common Shares PR Newswire (US) - 6/17/2019 6:00:00 PM
Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (s-3asr) Edgar (US Regulatory) - 6/17/2019 5:15:27 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/23/2019 6:39:24 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/23/2019 6:38:26 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/23/2019 6:37:19 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/23/2019 6:36:03 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/23/2019 6:35:30 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/23/2019 6:34:48 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/22/2019 5:19:50 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/8/2019 5:33:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/8/2019 6:44:00 AM
Biohaven Announces Expanded Safety And Preliminary Preventive Efficacy Data From Ongoing Long-Term Safety Study, And Presents... PR Newswire (US) - 5/7/2019 11:30:00 PM
Biohaven Advances Late Stage Clinical Programs And Novel Targets From Neuroinnovation Platforms PR Newswire (US) - 5/7/2019 11:15:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/7/2019 4:54:52 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/7/2019 11:31:55 AM
Biohaven Pharmaceuticals Reports First Quarter 2019 Financial Results And Advancements In Neuroinnovation Platforms PR Newswire (US) - 5/7/2019 6:55:00 AM
Biohaven Announces Late-Breaking Oral Presentation Of Rimegepant Zydis® ODT Phase 3 Results At American Academy Of Neurology... PR Newswire (US) - 5/3/2019 7:30:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 5/1/2019 6:03:29 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/16/2019 7:24:37 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/11/2019 5:24:22 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/11/2019 5:19:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/8/2019 6:08:03 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/5/2019 5:56:13 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/5/2019 5:55:05 PM
investor86   Tuesday, 06/19/18 08:20:50 AM
Re: crudeoil24 post# 7
Post # of 11 
Low volume, hope this take off.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist